
skinnyRx Reviews
25% off your first order
Last updated: Sep 2, 2026
Medically reviewed by Francheska Capistrano, RMT, MPH · · How we review
Medically reviewed by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed on Reviewed · Written by Treatments Hub Research Team
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
skinnyRx delivers a streamlined, physician-guided weight loss experience focused on getting patients started quickly. A solid option for people who prefer simplicity over extensive support programs.
skinnyRx offers a straightforward path to physician-prescribed GLP-1 weight loss treatment. Their platform connects patients with licensed providers who evaluate eligibility and prescribe compounded semaglutide or tirzepatide.
Key Features
- Physician-prescribed GLP-1 medications
- Compounded semaglutide and tirzepatide available
- Fast nationwide home delivery
- Online medical evaluation process
- Ongoing provider support included
Treatment Options
- Compounded semaglutide (injectable)
- Compounded tirzepatide (injectable)
- Graduated dosing protocols
Pricing
skinnyRx offers competitive monthly pricing for compounded GLP-1 medications. Plans include physician consultations, medication, and home delivery.
No long-term contracts required.
Pros
- Simple and fast online enrollment process
- Both semaglutide and tirzepatide options
- Physician oversight for all prescriptions
- Home delivery included in all plans
- No long-term commitment required
Cons
- Limited information on pricing before sign-up
- No behavioral coaching or nutrition support
- Brand-name medications not available
Who It's Best For
- People who want a fast, no-hassle path to GLP-1 medication
- Those looking for compounded medication options
- Patients who prefer a simple online process without extras
Final Verdict
skinnyRx delivers a streamlined, physician-guided weight loss experience focused on getting patients started quickly. A solid option for people who prefer simplicity over extensive support programs.
skinnyRx Review: FAQs
Is skinnyRx legit?
skinnyRx offers a straightforward path to physician-prescribed GLP-1 weight loss treatment. Their platform connects patients with licensed providers who evaluate eligibility and prescribe compounded semaglutide or tirzepatide.
How much does skinnyRx cost?
skinnyRx offers competitive monthly pricing for compounded GLP-1 medications. Plans include physician consultations, medication, and home delivery. No long-term contracts required.
What treatments does skinnyRx offer?
skinnyRx offers Compounded semaglutide (injectable), Compounded tirzepatide (injectable), Graduated dosing protocols.
Who is skinnyRx best for?
skinnyRx is best for People who want a fast, no-hassle path to GLP-1 medication; Those looking for compounded medication options; Patients who prefer a simple online process without extras.
Is skinnyRx worth it?
skinnyRx delivers a streamlined, physician-guided weight loss experience focused on getting patients started quickly. A solid option for people who prefer simplicity over extensive support programs.
Not sure if skinnyRx is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Guides
Sources & methodology
We built this review of skinnyRx from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- skinnyRx - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: public Reddit discussions and independent YouTube reviews. We report what these sources say - we never fold them into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
